The Company's lead product, a unique once-daily formulation of tramadol, is being commercially launched in key markets globally. The Company also has a robust pipeline of follow-on products in both ...

SAN DIEGO, CA / ACCESS Newswire / January 7, 2026 / Revelation Biosciences, Inc. (NASDAQ:REVB) (the "Company" or ...

MIAMI, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for the treatment of cardiometabolic and ...

Event Overview: Formulation Development is a key element in the pharmaceutical development process. There is an increasing trend by companies to outsource not just this service, but an integrated ...

Shin Nippon Biomedical Laboratories, Ltd. (SNBL) is currently developing an intranasal form of zolmitriptan (TRZ), a drug for relief of migraine headaches. SNBL today announces the completion and ...

Based on formulation simplicity and blinding capability, hard gelatin capsules are preferrable compared with other oral solid dosage forms, including tablets, in the early clinical phases of drug ...

Discover how early CMC, process optimization, and formulation strategy drive scalable, commercially viable drugs.

Grand Cayman, Cayman Islands, April 23, 2025 (GLOBE NEWSWIRE) -- Silexion Therapeutics Corp. (NASDAQ: SLXN) (“Silexion” or the “Company”), a clinical-stage biotechnology company pioneering RNA ...

A total of 39 patients with hematologic malignancy were enrolled (14 on IV SAHA and 25 on oral SAHA), of whom 35 were treated. The spectrum of diseases included patients with diffuse large B-cell ...

As efforts to develop an effective vaccine for COVID-19 continue, in parallel, drug developers are investigating the effectiveness of existing drugs at treating patients with COVID-19. The ...

The oral probiotic supplement industry is experiencing a fundamental transformation in 2025, as consumers increasingly demand ingredient transparency and clinical research backing over marketing ...